ArticleFrontiers in research metrics and analytics2026
Evaluating large language models for abstract evaluation tasks: an empirical study.
Article in Frontiers in research metrics and analytics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Large language models (LLMs) show great promise as tools for assisting scientific peer review, but their agreement with human experts in quantitative assessment of academic content needs further investigation. This study examined ChatGPT-5, Gemini-3-Pro, and Claude-Sonnet-4.5's consistency and reliability in evaluating conference abstracts compared to one another and to human reviewers. Methods: Three LLMs independently graded 160 abstracts from a regional conference, while 14 human reviewers each assessed a subset using an identical rubric with eight criteria scored on a 1-5 scale. We compared AI and human scoring patterns using boxplots, calculated intraclass correlation coefficients (ICCs) for inter-rater reliability both among LLMs and between human and LLMs, and examined Bland-Altman plots to identify agreement patterns and systematic bias. Results: Three LLMs demonstrated high internal consistency with narrow interquartile ranges and few outliers in composite scores, while human reviewers exhibited greater scoring variability. LLMs also achieved good-to-excellent agreement with each other across all criteria (ICCs: 0.59-0.87). ChatGPT and Claude reached moderate agreement with human reviewers on overall quality and content-specific criteria, with ICCs = 0.45-0.60 for composite score, impression, clarity, objective, and results. The two LLMs' concordance with humans achieved fair levels on subjective dimensions, with ICC ranging from 0.23-0.38 for impact, engagement, and applicability. Gemini performed notably worse, showing fair agreement on half the criteria and poor reliability on impact and applicability. Bland-Altman analysis revealed acceptable or negligible systematic bias, with mean differences of 0.24 (ChatGPT), 0.42 (Gemini), and -0.02 (Claude) from human mean ratings. Discussion: With appropriate model selection, LLMs could reach moderate agreement with human experts on abstract overall quality and objective criteria, supporting their potential use for pre-screening low-quality submissions or serving as additional reviewers. Their ability to apply rubrics consistently across large volumes of abstracts offers advantages in efficiency and standardization that exceed human feasibility. However, LLMs' reduced performance on subjective dimensions indicates that they should complement rather than replace human judgment in abstract evaluation, with expert review remaining essential for comprehensive assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.